ACADIA PHARMACEUTICALS INC. Jointly Owned Utility Plant, Proportionate Ownership Share
ACADIA PHARMACEUTICALS INC. (ACAD) had Jointly Owned Utility Plant, Proportionate Ownership Share of 50.00% as of 2022-01-31, per its 10-K filed 2022-03-01.
Discontinued › Notes
us-gaap:JointlyOwnedUtilityPlantProportionateOwnershipShare · last filed 2022-03-01
- 2022-01-31: Jointly Owned Utility Plant, Proportionate Ownership Share 50.00%.
| Period end | Jointly Owned Utility Plant, Proportionate Ownership Share |
|---|---|
| 2022-01-31 | 50.00% 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |